MD, Viral and Metabolic Liver Unit Head and Associate Professor of Medicine in the Department of Hepatology
Institution: Saint-Antoine Hospital
Biography of Lawrence SERFATY
Lawrence Serfaty, MD, is the Viral and Metabolic Liver Unit Head and Associate Professor of Medicine in the Department of Hepatology, Saint-Antoine Hospital, Paris, France. Dr Serfaty received his Medical degree from University of Paris-Sud and completed his Medical training at Saint-Antoine Hospital.
Dr Serfaty began his research career studying viral HCV in the early 1990s and then focused on potential mechanisms of steatosis and its role in fibrogenesis in chronic HCV. He then extended his field of research to non-alcoholic fatty liver disease (NAFLD), by investigating mechanisms of liver injury associated with insulin resistance in obese patients as well as those with HIV-associated lipodystrophy.
Dr Serfaty has been involved in a number of trials evaluating new anti-HCV direct-acting antivirals. In this setting, he recently published important papers regarding the impact of metabolic factors on the efficacy of protease inhibitor-based triple therapy. Dr Serfaty has published more than 130 indexed papers. He is a member of the French Association for the Study of the Liver (AFEF) and the European Association for the Study of the Liver (EASL).